$ Value
$0
Shares
205,000
Price
$0
Filed
Apr 22
Insider
Name
Gallagher Kathleen P.
Title
See Remarks
CIK
0002048409
Roles
Transaction Details
Transaction Date
2026-04-20
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
205,000
Footnotes
Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. | Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
Filing Info
Gallagher Kathleen P.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-20 | RNA | A | $0 |
| 2026-04-20 | RNA | A | $0 |
| 2025-09-02 | RNA | ▼ | $9K |
| 2025-06-17 | RNA | ▼ | $28K |
| 2025-06-02 | RNA | M | $98K |
| 2025-06-02 | RNA | ▼ | $191K |
| 2025-06-02 | RNA | M | $0 |
| 2025-05-01 | RNA | M | $98K |
| 2025-05-01 | RNA | ▼ | $190K |
| 2025-05-01 | RNA | M | $0 |
Other Insiders at RNA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hughes Steven George
Chief Medical Officer
|
— | — | 2026-04-20 |
|
Gallagher Kathleen P.
See Remarks
|
— | — | 2026-04-20 |
|
Kenney Stephanie
See Remarks
|
— | — | 2026-04-20 |
|
Winslow Brendan R.
Chief Financial Officer
|
— | — | 2026-04-20 |
|
Hoyos Rocio Martin
Chief Strategy Officer
|
— | — | 2026-04-20 |
|
Younis Husam
Chief Scientific Officer
|
— | — | 2026-04-20 |